National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN Volasertib Research Grant Opportunity – Submit by October 30, 2014
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources


Moffitt Cancer Center
Tampa, Florida
800.456.3434 (888.MOFFITT)
www.moffitt.org

Adult Oncology Services

Introduction

Moffitt Cancer Center is a not-a-for-profit institution which includes a hospital as well as a freestanding outpatient care facility, a major research institute consisting of more than 800 research faculty and research support staff combined, more than 300 physicians including residents and interns, a freestanding screening and prevention center providing a wide array of outreach and educational activities for the general public and select underserved populations and M2Gen®, a for-profit subsidiary.

Moffitt Cancer Center is a National Cancer Institute Comprehensive Cancer Center with an interdisciplinary approach to research and patient care. Moffitt's NCI Comprehensive Cancer Center status signifies its membership among an elite group of NCI centers nationwide whose singular focus is the rapid translation of research discoveries to directly benefit people with cancer. Moffitt Cancer Center also consistently has been named among "America's Best Hospitals" for cancer care by U.S. News & World Report.

Moffitt Cancer Center's scientific programs are integrally linked. The Moffitt Research Institute includes programs within the divisions of Basic Science, Population Science, Clinical Science, Translational Science and Education & Training. Clinical trials encompassing new and established procedures in chemotherapy, surgery, radiation and genetic immunotherapy are available for most diseases. All research, no matter how fundamental, is regularly scrutinized for its translational potential. Moffitt recognizes the critical role a cancer center can play in this transition from concept to clinical intervention. After more than 25 years, Moffitt’s mission remains totally focused on "contributing to the prevention and cure of cancer."

The Florida Legislature created the cancer center in the early 1980s to meet a clear and compelling need to respond to Florida's "cancer epidemic." Construction of the original, 380,000 square foot hospital facility was funded with $70 million from the state's cigarette tax, allowing the center to open in 1986. Since then, Moffitt Cancer Center has become a large institution employing more than 4,300 staff working in nine buildings totaling nearly 1.4 million square feet.

As a National Cancer Institute Comprehensive Cancer Center, Moffitt Cancer Center has two responsibilities: to continue our work in scientific innovation and to share this information with the community we serve. Recognizing that we must reach beyond our walls to fulfill these responsibilities, Moffitt is building a strategic network of the highest quality physicians and facilities in Florida. In addition, Moffitt Cancer Center has instituted a new program to perform state-of-the-art cancer research called "Total Cancer Care" (TCC). Joining with its partners to create a new frontier in cancer research, Moffitt is using health information technology to revolutionize the delivery of cancer care and accelerate the development of new lifesaving therapies.

Focused on providing the right care, at the right place, at the right time, the program is based on the ability to acquire blood and tumor samples from thousands of cancer patients at Moffitt and at affiliated hospitals and oncology practices throughout Florida. Every individual is different, with a different fingerprint, and every tumor is unique as well. While cancer can be classified by its site of origin (lung, breast, colon, prostate), there are, in fact, many different types of each of these cancers. Today, physicians treat most cancer patients with the standard protocol, but in reality, only a few patients may benefit from that specific drug -- individual patients with the same kind of cancer don't always respond to standard treatment for that cancer in the same way.

Recent technological advancements now make it possible to test each tumor for approximately 30,000 genes. These genes provide a "molecular" fingerprint that is unique for each tumor just like the lines on a person's fingertips uniquely identify that person. By studying this "molecular" fingerprint, scientists will eventually develop new drug therapies that are personalized for each individual. Information about which drugs are working best will be used to prevent, detect, treat, and even cure different types of cancer - thus streamlining the drug development process.

Clinical Programs

Moffitt's academic and clinical services are organized into 14 disease-oriented programs consisting of surgeons, radiation oncologists, medical oncologists, pathologists, nurses, data managers, administrative managers, and other appropriate support personnel. The objectives of the programs are to provide interdisciplinary evaluation of and treatment plans for cancer patients, develop and conduct clinical research trials, establish translational linkages with appropriate basic science programs, and provide educational programs and training for medical students, house staff physicians, fellows and the community.

Research

Research at Moffitt encompasses more than just laboratories and new drug therapies. Basic scientists, funded by state and federal grants, probe the "why" and "how" of healthy cells that change to cancer, while physician-scientists bring those discoveries to the patient by offering the latest investigational treatments. The Center has a number of research programs including molecular oncology, immunology, drug discovery, experimental therapeutics, genetic immunotherapy, behavioral oncology, cancer screening, prevention and early detection, digital imaging, tobacco research and intervention, and molecular screening.

Interdisciplinary Teams

The clinical services at Moffitt Cancer Center have been organized into 14 disease-oriented, interdisciplinary programs consisting of team members from across the spectrum of services. Team members meet for weekly tumor boards. In addition, they attend/participate in specific case conferences as needed as well as teleconferences with referring physicians and other institutions.

General Information

General Information

800.456.3434

Referring Physician/MD Hot Line

888.MOFFITT (888.663.3488)

Location

Tampa, Florida

Facility

  • Moffitt Cancer Center (Hospital)
  • Moffitt Research Center
  • Moffitt Clinic
  • Moffitt Cancer Screening and Prevention Center
  • Vincent A. Stabile Research Building
    Moffitt at International Plaza

Travel Assistance

Patient Relations, or when appropriate International Relations, can assist with travel arrangements.

Lodging

  • ACS Hope Lodge (on campus)
  • Magnolia Lodging Program

Hope Lodge can be arranged by calling the American Cancer Society at
813.254.3630 or Moffitt's Psychosocial Department at 800.456.3434. Magnolia Lodging Program can be arranged through Moffitt's Patient Relations Program or Psychosocial Department by calling 800.456.3434.

Treatment

Multidisciplinary Clinics

Please call the main Moffitt number at 800.456.3434 toll-free and ask for a specific program, or call 888.MOFFITT (888.663.3488 or visit our web site at www.moffitt.org and click on clinical programs.

Disease Center

Contact Number

Blood & Marrow Transplant Program

800.456.3434 or 888.MOFFITT

Comprehensive Breast Cancer Program

800.456.3434 or 888.MOFFITT

Cutaneous Oncology Program

800.456.3434 or 888.MOFFITT

Gastrointestinal Tumor Program

800.456.3434 or 888.MOFFITT

Genitourinary Oncology Program

800.456.3434 or 888.MOFFITT

Gynecologic Oncology Program

800.456.3434 or 888.MOFFITT

Head & Neck Oncology Program

800.456.3434 or 888.MOFFITT

Malignant Hematology Program

800.456.3434 or 888.MOFFITT

Neuro-Oncology Program

800.456.3434 or 888.MOFFITT

Psychosocial & Palliative Care Program

800.456.3434 or 888.MOFFITT

Radiation Oncology Program

800.456.3434 or 888.MOFFITT

Sarcoma Program

800.456.3434 or 888.MOFFITT

Senior Oncology Program (70+)

800.456.3434 or 888.MOFFITT

Thoracic Oncology Program

800.456.3434 or 888.MOFFITT

Stem Cell Transplant Program

Diseases: Breast Cancer, Leukemia, and Lymphoma

Both autologous and allogenic transplants are provided. Breast cancer, leukemia, and lymphoma are all being treated through transplants.

Integrative Medicine

Moffitt’s evidence-based Integrative Medicine Program offers healing and wellness services and integrates safe and effective complementary therapies with conventional treatments to improve the quality of life for our patients during and after cancer treatment.  Key elements include acupuncture, nutritional counseling, exercise assessment, massage therapy, yoga, and tai chi.

The program also conducts research on complementary therapies and incorporates the latest advances into patient care to reduce the side effects and symptoms associated with cancer treatments.

Information about the program as well as all of Moffitt's research studies and services can be accessed at 888.MOFFITT or www.moffitt.org.

Cancer Prevention and Screening

  • Moffitt provides smoking cessation programs, nutritional counseling, and genetic counseling to the community
  • Moffitt has a cancer screening and prevention center that provides screening and counseling.
  • Through its community outreach programs, Moffitt provides mammography screening and follow-up to rural farm workers and underserved populations
  • Moffitt’s Mole Patrol®, a team of skin cancer specialists, offers free screenings for skin cancers, including melanoma, at beachside locations and elsewhere throughout the state.

Support Services

Moffitt offers a number of support groups for cancer patients including FACTors (breast cancer), Man-to-Man (prostate cancer), Chatterbox (laryngectomee), lung cancer, and others.

The Psychosocial Department offers counseling for patients and families alike.

Moffitt has an excellent Survivorship Program for cancer patients and their families

The Psychosocial staff and the Patient Relations staff are available to address employment and childcare issues.

Supportive Care

Pain Service

Moffitt's Pain Care and Palliative Care are under the aegis of the Psychosocial Department.

Home Care/Hospice Service

Moffitt refers patients who are appropriate for and wish to receive hospice care to local hospices, based on the geographic location of the patient’s residence.

Nutrition Service

Services are provided through the Nutrition Department and registered/clinical dietitians are available.

Special Expertise

Cooperative Group Membership

Cooperative Group Membership List

  • Southwestern Oncology Group (SWOG)
  • Radiation Therapy Oncology Group (RTOG)
  • Gynecologic Oncology Group (GOG)
  • New Approaches to Brain Tumor Therapy (NABTT)
  • Sarcoma Alliance for Research through Collaboration (SARC)
  • American College of Radiology Imaging Network (ACRIN)
  • National Surgical Adjuvant Breast and Bowel Project (NSABP)

Activities in Cooperative Group

The Cancer Center is a fully active member of the Southwestern Oncology Group (SWOG), the Radiation Therapy Oncology Group (RTOG), the Gynecologic Oncology Group (GOG), and the New Approaches to Brain Tumor Therapy (NABTT) consortium. Membership in these National Cancer Institute-sponsored groups means that a full array of NCI studies is available to Moffitt patients.

Average Number of Adult Clinical Trials

The average number of interventional clinical trials for adults at Moffitt is 400.

Clinical and Research Efforts

Adult Oncology Program

No. of Inpatient Beds (Medical/Surgical)

No. of Admissions*

Average Length of Stay (days)

No. of New Outpatients*

No. of Oncologists (Medical and Surgical)

206

9,373

6.2

330,363 (visits)

320

*FY13 (July 1, 2012 - June 30, 2013) Represents outpatient visits